Log in to save to my catalogue

Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-relat...

Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-relat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c26ef5643bfb438e97f3c578fbbd923b

Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan

About this item

Full title

Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan

Publisher

England: BioMed Central Ltd

Journal title

BMC ophthalmology, 2022-01, Vol.22 (1), p.25-25, Article 25

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The management of neovascular age-related macular degeneration (nAMD) has taken a major stride forward with the advent of anti-VEGF agents. The treat-and-extend (T&E) approach is a refined management strategy, tailoring to the individual patient's disease course and treatment outcome. To provide guidance to implementing anti-VEGF T&E regimens for n...

Alternative Titles

Full title

Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c26ef5643bfb438e97f3c578fbbd923b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c26ef5643bfb438e97f3c578fbbd923b

Other Identifiers

ISSN

1471-2415

E-ISSN

1471-2415

DOI

10.1186/s12886-021-02231-8

How to access this item